Interna Technologies B.v.

Sanne Weijzen

Roeland Quirinus Jozef Schaapveld

Willemijn Maria Gommans

Eugene Berezikov

Jacobus Antonius Schalken

Arjan Willem Griffioen

Rick Jan Van Haastert

Petronella Innocentia Van Noort

Edwin Pieter Johan Gerard Cuppen

Andreas Alphons Franciscus Ludovicus Van Puijenbroek

Negar Babae

Meriem Bourajjaj

Gerardus Wihelmus Christiaan Theodoor Verhaegh

Andreas Alphons Van Puijenbroek

Willemjin Maria Gommans

Judith Rosina Van Beijnum

Gerardus Wilhelmus Christiaan Theodoor Verhaegh

Judith Rosina Van Biejnum

Andreas Alphons Franciscus Ludovicus Van Piujenbroek

Andreas Alphons Franciscus L Van Puijenbroek

The invention relates to the diagnostic and therapeutic uses of a miRNA molecule, an equivalent or a source thereof in a disease and condition associated with neo-angiogenesis.

MiRNA for treating diseases and conditions associated with neo-angiogenesis

The invention relates to the diagnostic and therapeutic uses of a miRNA molecule or an equivalent thereof wherein a source of said miRNA molecule or equivalent thereof comprises at least 80 nucleotides and comprises a motif having at least 98% identity with the motif represented by SEQ ID NO:1 or a source thereof in a disease and condition associated with EMT (Epithelial to Mesenchymal Transition).

MiRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with EMT

Growing community of inventors

Bilthoven, Netherlands

Sanne Weijzen